{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:35:12Z","timestamp":1793018112629,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s13555-026-01928-2","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:27:30Z","timestamp":1790926050000},"page":"5669-5686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monitoring the Response to JAK Inhibitor Treatment in Alopecia Areata Using Reflectance Confocal Microscopy and Videotrichoscopy: A 60-Week Observational Study"],"prefix":"10.1007","volume":"16","author":[{"given":"Kinga","family":"Ko\u0142cz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagienka","family":"W\u0142odyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5573-1754","authenticated-orcid":false,"given":"Adam","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"1928_CR1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/jid.2013.464","volume":"134","author":"SA Mirzoyev","year":"1990","unstructured":"Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009. J Investig Dermatol. 1990;134:1141\u20132. https:\/\/doi.org\/10.1038\/jid.2013.464.","journal-title":"J Investig Dermatol"},{"key":"1928_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/1346-8138.14283","volume":"45","author":"A Wa\u015bkiel","year":"2018","unstructured":"Wa\u015bkiel A, Rakowska A, Sikora M, Olszewska M, Rudnicka L. Trichoscopy of alopecia areata: an update. J Dermatol. 2018;45:692\u2013700. https:\/\/doi.org\/10.1111\/1346-8138.14283.","journal-title":"J Dermatol"},{"key":"1928_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78298","volume":"17","author":"YA Abarca","year":"2025","unstructured":"Abarca YA, Scott-Emuakpor R, Tirth J, et al. Alopecia areata: understanding the pathophysiology and advancements in treatment modalities. Cureus. 2025;17:e78298. https:\/\/doi.org\/10.7759\/cureus.78298.","journal-title":"Cureus"},{"key":"1928_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/pde.13387","volume":"35","author":"I Wohlmuth-Wieser","year":"2018","unstructured":"Wohlmuth-Wieser I, Osei JS, Norris D, et al. Childhood alopecia areata-data from the National Alopecia Areata Registry. Pediatr Dermatol. 2018;35:164\u20139. https:\/\/doi.org\/10.1111\/pde.13387.","journal-title":"Pediatr Dermatol"},{"key":"1928_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/jdv.19768","volume":"38","author":"L Rudnicka","year":"2024","unstructured":"Rudnicka L, Arenbergerova M, Grimalt R, et al. European expert consensus statement on the systemic treatment of alopecia areata. J Eur Acad Dermatol Venereol. 2024;38:687\u201394. https:\/\/doi.org\/10.1111\/jdv.19768.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1928_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00403-025-03890-z","volume":"317","author":"TY Zhang","year":"2025","unstructured":"Zhang TY, Zeng YP. Off-label use of JAK1 inhibitor upadacitinib in dermatology. Arch Dermatol Res. 2025;317:363. https:\/\/doi.org\/10.1007\/s00403-025-03890-z.","journal-title":"Arch Dermatol Res"},{"key":"1928_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3315\/jdcr.2008.1017","volume":"2","author":"L Rudnicka","year":"2008","unstructured":"Rudnicka L, Olszewska M, Rakowska A. In vivo reflectance confocal microscopy: usefulness for diagnosing hair diseases. J Dermatol Case Rep. 2008;2:55\u20139. https:\/\/doi.org\/10.3315\/jdcr.2008.1017.","journal-title":"J Dermatol Case Rep"},{"key":"1928_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00403-016-1657-4","volume":"308","author":"M Ardig\u00f2","year":"2016","unstructured":"Ardig\u00f2 M, Agozzino M, Franceschini C, et al. Reflectance confocal microscopy for scarring and non-scarring alopecia real-time assessment. Arch Dermatol Res. 2016;308:309\u201318. https:\/\/doi.org\/10.1007\/s00403-016-1657-4.","journal-title":"Arch Dermatol Res"},{"key":"1928_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jaad.2021.08.043","volume":"86","author":"BA King","year":"2022","unstructured":"King BA, Mesinkovska NA, Craiglow B, et al. Development of the alopecia areata scale for clinical use: results of an academic-industry collaborative effort. J Am Acad Dermatol. 2022;86:359\u201364. https:\/\/doi.org\/10.1016\/j.jaad.2021.08.043.","journal-title":"J Am Acad Dermatol"},{"key":"1928_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5114\/dr.2023.127704","volume":"110","author":"A Rakowska","year":"2023","unstructured":"Rakowska A, Rudnicka L, Olszewska M, et al. Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment. Dermatol Rev. 2023;110:89\u2013100. https:\/\/doi.org\/10.5114\/dr.2023.127704.","journal-title":"Dermatol Rev"},{"key":"1928_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40257-023-00764-w","volume":"24","author":"O Kwon","year":"2023","unstructured":"Kwon O, Senna MM, Sinclair R, et al. Efficacy and safety of baricitinib in patients with severe alopecia areata over 52\u00a0weeks of continuous therapy in two phase\u00a0III trials (BRAVE-AA1 and BRAVE-AA2). Am J Clin Dermatol. 2023;24:443\u201351. https:\/\/doi.org\/10.1007\/s40257-023-00764-w.","journal-title":"Am J Clin Dermatol"},{"key":"1928_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2444494","volume":"36","author":"CA Vignoli","year":"2025","unstructured":"Vignoli CA, Gargiulo L, Ibba L, et al. Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study. J Dermatol Treat. 2025;36:2444494. https:\/\/doi.org\/10.1080\/09546634.2024.2444494.","journal-title":"J Dermatol Treat"},{"key":"1928_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaad.2022.12.056","volume":"89","author":"A Flora","year":"2023","unstructured":"Flora A, Kozera E, Frew JW. Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: a retrospective cohort study. J Am Acad Dermatol. 2023;89:137\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2022.12.056.","journal-title":"J Am Acad Dermatol"},{"key":"1928_CR14","unstructured":"AbbVie. AbbVie Announces Positive Topline Results from Phase 3 UP-AA Trial Evaluating Upadacitinib (RINVOQ\u00ae) for Alopecia Areata. https:\/\/news.abbvie.com\/2025-07-30-AbbVie-Announces-Positive-Topline-Results-from-Phase-3-UP-AA-Trial-Evaluating-Upadacitinib-RINVOQ-R-for-Alopecia-Areata. Accessed 30 July 2025."},{"issue":"3","key":"1928_CR15","doi-asserted-by":"publisher","first-page":"17011","DOI":"10.1038\/nrdp.2017.11","volume":"16","author":"CH Pratt","year":"2017","unstructured":"Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;16(3):17011. https:\/\/doi.org\/10.1038\/nrdp.2017.11.","journal-title":"Nat Rev Dis Primers"},{"key":"1928_CR16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8320","volume":"12","author":"F Asghar","year":"2020","unstructured":"Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen effluvium: a review of the literature. Cureus. 2020;12:e8320. https:\/\/doi.org\/10.7759\/cureus.8320.","journal-title":"Cureus"},{"key":"1928_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40257-025-00932-0","volume":"26","author":"B King","year":"2025","unstructured":"King B, Mostaghimi A, Shimomura Y, et al. Safety of baricitinib in adults with severe alopecia areata from two phase III trials over a median of 2.3\u00a0years and up to 4\u00a0years of treatment. Am J Clin Dermatol. 2025;26:611\u201322. https:\/\/doi.org\/10.1007\/s40257-025-00932-0.","journal-title":"Am J Clin Dermatol"},{"key":"1928_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.3645","volume":"20","author":"L Xing","year":"2014","unstructured":"Xing L, Dai Z, Jabbari A, et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med. 2014;20:1043\u20139. https:\/\/doi.org\/10.1038\/nm.3645.","journal-title":"Nat Med"},{"key":"1928_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2147\/CCID.S309215","volume":"14","author":"KL Dillon","year":"2021","unstructured":"Dillon KL. A comprehensive literature review of jak inhibitors in treatment of alopecia areata. Clin Cosmet Investig Dermatol. 2021;14:691\u2013714. https:\/\/doi.org\/10.2147\/CCID.S309215.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1928_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1577115","volume":"16","author":"Y Sun","year":"2025","unstructured":"Sun Y, Li Q, Zhang Y, Liu Y. Janus kinase inhibitors for alopecia areata: a review of clinical data. Front Immunol. 2025;16:1577115. https:\/\/doi.org\/10.3389\/fimmu.2025.1577115.","journal-title":"Front Immunol"},{"key":"1928_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13378","volume":"29","author":"MS Al-Dhubaibi","year":"2023","unstructured":"Al-Dhubaibi MS, Alsenaid A, Alhetheli G, Abd Elneam AI. Trichoscopy pattern in alopecia areata: a systematic review and meta-analysis. Skin Res Technol. 2023;29:e13378. https:\/\/doi.org\/10.1111\/srt.13378.","journal-title":"Skin Res Technol"},{"key":"1928_CR22","doi-asserted-by":"publisher","first-page":"T25","DOI":"10.1016\/j.ad.2022.08.027","volume":"114","author":"H G\u00f3mez-Quispe","year":"2023","unstructured":"G\u00f3mez-Quispe H, Mu\u00f1oz Moreno-Arrones O, Hermosa-Gelbard \u00c1, et al. Trichoscopy in alopecia areata. Actas Dermosifiliogr. 2023;114:T25\u201332. https:\/\/doi.org\/10.1016\/j.ad.2022.08.027.","journal-title":"Actas Dermosifiliogr"},{"key":"1928_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.4103\/0378-6323.110767","volume":"79","author":"S Ganjoo","year":"2013","unstructured":"Ganjoo S, Thappa DM. Dermoscopic evaluation of therapeutic response to an intralesional corticosteroid in the treatment of alopecia areata. Indian J Dermatol Venereol Leprol. 2013;79:408\u201317. https:\/\/doi.org\/10.4103\/0378-6323.110767.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1928_CR24","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/jocd.13739","volume":"20","author":"MM Fawzy","year":"2021","unstructured":"Fawzy MM, Abdel Hay R, Mohammed FN, et al. Trichoscopy as an evaluation method for alopecia areata treatment: a comparative study. J Cosmet Dermatol. 2021;20:1827\u201336. https:\/\/doi.org\/10.1111\/jocd.13739.","journal-title":"J Cosmet Dermatol"},{"key":"1928_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/ijt.ijt_102_17","volume":"10","author":"H Mahmoudi","year":"2018","unstructured":"Mahmoudi H, Salehi M, Moghadas S, et al. Dermoscopic findings in 126 patients with alopecia areata: a cross-sectional study. Int J Trichology. 2018;10:118\u201323. https:\/\/doi.org\/10.4103\/ijt.ijt_102_17.","journal-title":"Int J Trichology"},{"key":"1928_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/archdermatol.2010.288","volume":"147","author":"M Ardig\u00f2","year":"2011","unstructured":"Ardig\u00f2 M, Tosti A, Cameli N, et al. Reflectance confocal microscopy of the yellow dot pattern in alopecia areata. Arch Dermatol. 2011;147:61\u20134. https:\/\/doi.org\/10.1001\/archdermatol.2010.288.","journal-title":"Arch Dermatol"},{"key":"1928_CR27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jaad.2006.04.058","volume":"55","author":"EK Ross","year":"2006","unstructured":"Ross EK, Vincenzi C, Tosti A. Videodermoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol. 2006;55:799\u2013806. https:\/\/doi.org\/10.1016\/j.jaad.2006.04.058.","journal-title":"J Am Acad Dermatol"},{"key":"1928_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ddg.14689","volume":"20","author":"DA Lintzeri","year":"2022","unstructured":"Lintzeri DA, Constantinou A, Hillmann K, et al. Alopecia areata\u2014current understanding and management. JDDG. 2022;20:59\u201390. https:\/\/doi.org\/10.1111\/ddg.14689.","journal-title":"JDDG"},{"key":"1928_CR29","doi-asserted-by":"publisher","first-page":"T502","DOI":"10.1016\/j.ad.2023.05.014","volume":"114","author":"A Fernandez-Flores","year":"2023","unstructured":"Fernandez-Flores A, Cabo F. Histopathologic and trichoscopic correlations in nonscarring alopecias. Actas Dermosifiliogr. 2023;114:T502\u201311. https:\/\/doi.org\/10.1016\/j.ad.2023.05.014.","journal-title":"Actas Dermosifiliogr"},{"key":"1928_CR30","doi-asserted-by":"publisher","DOI":"10.1177\/09636897251382318","volume":"34","author":"K Kaewmungkun","year":"2025","unstructured":"Kaewmungkun K, Kaisang S, Yokhaphachon N, Parnpai R. Advanced medical treatments for hair loss. Cell Transplant. 2025;34:9636897251382318. https:\/\/doi.org\/10.1177\/09636897251382318.","journal-title":"Cell Transplant"},{"issue":"4","key":"1928_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4103\/ijd.ijd_346_23","volume":"69","author":"A Raheem","year":"2024","unstructured":"Raheem A, Al-Dhalimi M. Comparative study of trichoscopic features of alopecia areata between adults and children and between different body parts (scalp, beard, eyebrow, and moustache). Indian J Dermatol. 2024;69(4):285\u201391. https:\/\/doi.org\/10.4103\/ijd.ijd_346_23.","journal-title":"Indian J Dermatol"},{"key":"1928_CR32","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/1346-8138.17844","volume":"52","author":"M Ohyama","year":"2025","unstructured":"Ohyama M, Irisawa R, Uchiyama M, et al. Use of 5% topical minoxidil application for telogen effluvium: an open-label single-arm clinical trial. J Dermatol. 2025;52:1351\u20139. https:\/\/doi.org\/10.1111\/1346-8138.17844.","journal-title":"J Dermatol"},{"key":"1928_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.26574\/maedica.2023.18.2.333","volume":"18","author":"M Paun","year":"2023","unstructured":"Paun M, Tiplica GS. Non-invasive techniques for evaluating alopecia areata. Maedica (Bucur). 2023;18:333\u201341. https:\/\/doi.org\/10.26574\/maedica.2023.18.2.333.","journal-title":"Maedica (Bucur)"},{"key":"1928_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s0190-962270219-6","volume":"37","author":"DM Elston","year":"1997","unstructured":"Elston DM, McCollough ML, Bergfeld WF, et al. Eosinophils in fibrous tracts and near hair bulbs: a helpful diagnostic feature of alopecia areata. J Am Acad Dermatol. 1997;37:101\u20136. https:\/\/doi.org\/10.1016\/s0190-962270219-6.","journal-title":"J Am Acad Dermatol"},{"key":"1928_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s44368-025-00013-8","volume":"2","author":"E Akbaba","year":"2025","unstructured":"Akbaba E, Aydemir E, Ayaz F. Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives. Discov Immun. 2025;2:8. https:\/\/doi.org\/10.1007\/s44368-025-00013-8.","journal-title":"Discov Immun"},{"key":"1928_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ad.2014.07.006","volume":"106","author":"C Bern\u00e1rdez","year":"2015","unstructured":"Bern\u00e1rdez C, Molina-Ruiz AM, Requena L. Histopatolog\u00eda de las alopecias. Parte I: alopecias no cicatriciales. Actas Dermosifiliogr. 2015;106:158\u201367.","journal-title":"Actas Dermosifiliogr"},{"key":"1928_CR37","doi-asserted-by":"publisher","first-page":"e2024229","DOI":"10.5826\/dpc.1404a229","volume":"14","author":"M Starace","year":"2024","unstructured":"Starace M, De Carvalho N, Melo DF, et al. Concordance among in vivo reflectance confocal microscopy, trichoscopy, and histopathology in the evaluation of alopecia areata incognita. Dermatol Pract Concept. 2024;14:e2024229. https:\/\/doi.org\/10.5826\/dpc.1404a229.","journal-title":"Dermatol Pract Concept"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01928-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01928-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01928-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:04:05Z","timestamp":1793016245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01928-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1928"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01928-2","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"21 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kinga Ko\u0142cz, Jagienka W\u0142odyka declare that they have no conflict of interest. Adam Reich has worked as a consultant or speaker for AbbVie, Bioderma, Celgene, Chema Elektromet, Eli Lilly, Galderma, Janssen, Leo Pharma, Medac, Menlo Therapeutics, Novartis, Pierre-Fabre, Sandoz, and Trevi, and participated as principal investigator or subinvestigator in clinical trials sponsored by AbbVie, Drug Delivery Solutions Ltd, Galderma, Genentech, Janssen, Kymab Limited, Leo Pharma, Menlo Therapeutics, MetrioPharm, MSD, Novartis, Pfizer, and Trevi. Adam Reich is a member of the journal\u2019s Editorial Board. Adam Reich is an Editorial Board member of\n                      Dermatology and Therapy\n                      . Adam Reich was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Bioethics Committee of the University of Rzesz\u00f3w (Decision no. 2023\/04\/0023) and was conducted in accordance with the Helsinki Declaration of 1964 and its later amendments. All adult patients, and the parents\/legal guardians of children under 18\u00a0years of age, provided written informed consent to participate and to the publication of accompanying images.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}